Background {#Sec1}
==========

Meigs and Cass first reported cases that developed non-malignant ascites and/or pleural effusion in association with benign ovarian tumors such as fibroma, thecoma, and Brenner tumor \[[@CR1]\]. These effusions disappeared after the removal of the tumors. Thereafter, this symptom was associated with benign ovarian tumors and referred to as Meigs' syndrome. The same clinical pictures due to a malignant ovarian or pelvic tumor have been referred to as pseudo-Meigs' syndrome \[[@CR2], [@CR3]\].

The etiology of Meigs' and pseudo-Meigs' syndrome is not fully elucidated, and no large case series studies are currently available. We herein report a case with pseudo-Meigs' syndrome that developed both synchronous and metachronous metastases to the ovary from ascending colon cancer and review of the pertinent literature.

Case presentation {#Sec2}
=================

A 57-year-old female visited a hospital with a 2-month history of abdominal distension and voiding difficulty. Because of a large pelvic tumor detected on CT, she was referred to the Department of Gynecology at our hospital.

Massive pleural effusion on the right side and a small amount of left-sided pleural effusion were detected on CT (Fig. [1a](#Fig1){ref-type="fig"}). Furthermore, CT revealed a large pelvic tumor measuring 13 cm in diameter (Fig. [1b](#Fig1){ref-type="fig"}) and ascites. The cytology of pleural effusion showed no malignant cells. The serum tumor marker levels of CEA, CA19-9, and CA125 were 28.7 ng/ml, 60.6 U/ml, and 302 U/ml, respectively. She subsequently underwent emergent laparotomy due to the severe symptom of abdominal distention. The tumor originated from the left ovary, and left-sided oophorectomy was performed. Cytology of ascites showed no malignant cells, and the tumor measured 17 × 14 cm (Fig. [1c](#Fig1){ref-type="fig"}) and contained necrotic tissue (Fig. [1d](#Fig1){ref-type="fig"}). The histologic finding was tubular adenocarcinoma (Fig. [2a](#Fig2){ref-type="fig"}), and CK20 and CDX-2 were positive by immunohistochemistry (Fig. [2b](#Fig2){ref-type="fig"} [c](#Fig2){ref-type="fig"}), suggesting metastatic carcinoma from the colon. The Ki67 labeling index of the tumor was also very high (\>80 %) (Fig. [2d](#Fig2){ref-type="fig"}).Fig. 1**a** Chest CT revealed massive pleural effusion at the right side and a small amount of left-side pleural effusion. **b** Abdominal CT indicated a large pelvic tumor. **c** The tumor of the left-side ovary measured 17 × 14 cm and contained necrotic tissues (**d**) Fig. 2**a** Histologic finding was moderately differentiated adenocarcinoma and CK20 (+) (**b**) and CDX (+) (**c**) with immunohistochemistry, suggested metastatic carcinoma from the colon. The Ki67 labeling index of the tumor was very high (\>80 %) (**d**)

Left thoracic effusion disappeared at 3 days after the removal of the ovarian tumor. Subsequently, we examined the whole body to find the primary tumor site, then colon carcinoma of the cecum was detected by colonoscopy. The patient underwent right colectomy and lymph node dissection again. The operative finding indicated a normal right ovary. The pathologic finding indicated type 2 colon cancer measuring 4 × 4.5 cm (Fig. [3a](#Fig3){ref-type="fig"}), moderately differentiated adenocarcinoma with subserosal invasion, vascular permeation, and lymph node metastases (3/33) (Fig. [3b](#Fig3){ref-type="fig"}). She was treated with oral uracil/tegafur and leucovorin. However, 6 months after the operation, pleural effusion of the right side again developed (Fig. [4a](#Fig4){ref-type="fig"}), and the serum levels of CEA and CA125 were elevated at 105 ng/ml and 125 U/ml, respectively. CT again revealed a large ovarian tumor (Fig. [4b](#Fig4){ref-type="fig"}). The patient subsequently underwent right-sided oophorectomy and hysterectomy at 9 months after the left-sided oophorectomy. The tumor on the right-sided ovary measured 21 × 17 cm and was histologically confirmed to be metastatic colon cancer, the same as the previous tumor from the left ovary.Fig. 3**a** Type 2 colon cancer measuring 4 × 4.5 cm was seen. **b** Histologic finding indicated mod. ss, ly (+), v (2+), *n* + (3/33) Fig. 4**a** Six months after the operation, pleural effusion of the right side has developed again. **b** CT revealed huge ovarian tumor again

Pleural effusion and ascites disappeared in a few days after the operation. She received 9 cycles of FOLFOX-4 chemotherapy (oxaliplatin 80 mg/m^2^ div at day 1, 5-Fu 600 mg/m^2^, and levofolinate 100 mg/m^2^ div at days 1 and 2) and has remained alive for 7 years with no recurrence.

Discussion and review of the literature {#Sec3}
---------------------------------------

Pseudo-Meigs' syndrome is defined as a condition with ascites and pleural effusion that is improved after the removal of an ovarian or pelvic tumor including both benign and malignant ovarian tumors. The primary sites of malignant disease can vary and include an ovarian malignant tumor \[[@CR4]\], leiomyoma \[[@CR5]\], gastric cancer \[[@CR6]\], breast cancer \[[@CR7], [@CR8]\], and colorectal cancer \[[@CR9]\].

Although the etiology of development of ascites and pleural effusion was not elucidated well, the following explanation has been proposed. Chronic transudation of interstitial edema of a large tumor may cause the persistent retention of ascites \[[@CR10]\]. Alternatively, the stromal edema and transudation was caused by an imbalance between arterial and venous blood flow of a large tumor \[[@CR11]\]. Furthermore, pleural effusion develops through trans-diaphragmatic lymphatic vessels \[[@CR12]\]. Additionally, a correlation with VEGF has been recently suggested \[[@CR13]\].

According to a search using the PubMed and Japanese MEDLINE databases (during the period of 1963--2015), 28 cases were reported cases (7 reports published in English and 21 reports published in Japanese with English abstracts). We reviewed the clinical data of the 29 cases, including the present case (Table [1](#Tab1){ref-type="table"}).Table 1Review of literatures of pseudo-Meigs' syndrome due to ovarian metastases from colon cancerNumberAuthorYear (ref)Age (years)Colon cancerOnset S or MEffusionsSerum CA125 (U/ml)Ovarian tumorPrognosis (months)Primary sitePathologyAscitesPleuralSite R or LSize (cm) R/LSurgical procedures1Ryan RJ1972 \[[@CR9]\]38TndMNoRightndR15 × 20BSOAlive (120)2Tanimura A1990 \[[@CR14]\]40DWellSYesBilateral1400R/LndBSOnd3Matsuzaki M1992 \[[@CR15]\]39RmodSYesBilateralndR24 × 22ROAlive (12)4Furumoto T1993 \[[@CR16]\]75RmodSYesRight422R/Lnd/21 × 12BSOAlive (12)5Nagakura S2000 \[[@CR17]\]53SWellSYesRightndR/L18 × 18/12 × 12BSO ATHAlive (52)6Koide A2002 \[[@CR18]\]52SWellSYesBilateral902L30 × 25LOAlive (10)7Inokuma S2002 \[[@CR19]\]42RSmodSYesRight395L16 × 9BSO ATHAlive (42)8Ohsawa T2003 \[[@CR12]\]41SmodSYesBilateral835R/L16 × 12/15 × 13BSODied (8)9Hatada T2003 \[[@CR20]\]52SWellSYesBilateral902L30 × 25BSO ATHAlive (19)10Kobayashi Y2003 \[[@CR21]\]48AWellSYesBilateral207R/L14 × 7/15 × 11BSO ATHAlive (19)11Feldman ED2004 \[[@CR22]\]49CndMNoLeft557R16BSOAlive (6)12Shundo Y2004 \[[@CR23]\]43SWellSYesRight81R/L12 × 10/3 × 2BSO ATHDied (24)13Motoyama K2005 \[[@CR24]\]48AmodSYesRight312R/L4 × 7/21 × 19BSO ATHAlive (12)14Sobajima J2007 \[[@CR25]\]54SmodSYesRight787R/L18 × 12/ndBSODied (12)15Ohsawa T2007 \[[@CR26]\]32SWellSYesBilateral595R/L17 × 13/3.5 × 2BSO ATHAlive (24)16Rubinstein Y2009 \[[@CR27]\]61CndSYesBilateral954R/Lnd/17BSOnd17Ikeda Y2009 \[[@CR28]\]53SmodSYesBilateral618R/L21 × 15/30 × 17BSOAlive (8)18Miki T2010 \[[@CR29]\]54DmodSYesBilateral327R18BSOAlive (14)19Murakami H2010 \[[@CR30]\]45SporMYesRight167R/L4 × 2/16 × 12BSOAlive (6)20Murakami H2010 \[[@CR31]\]53RWellMYesRight705RndRODied (4)21Ishii M2010 \[[@CR32]\]58SWellSYesLeftndL21 × 20BSOAlive (12)22Okuchi Y2010 \[[@CR13]\]43RmodMYesRight515L11 × 8BSODied (12)23Komatsu H2011 \[[@CR33]\]49AmodSYesRight67R/L15 × 12/10 × 8BSO ATHAlive (25)24Maeda H2011 \[[@CR34]\]58SWellSYesRight921R/L15/ndBSOAlive (10)25Iwagami Y2011 \[[@CR35]\]36SmodMYesRight427L21 × 17BSO ATHAlive (10)26Saito H2012 \[[@CR36]\]44SWellSYesBilateral576R22 × 22BSOnd27Iinuma A2014 \[[@CR37]\]55AWellSYesright912L19 × 20LOAlive (10)28Yachi T2015 \[[@CR38]\]65AWellMYesBilateral669R13 × 10ROAlive (27)29Present casena57AWellS, MYesBilateral302R/L17 × 14/21 × 17LO ROAlive (89)*C* cecum, *A* ascending, *T* transverse, *D* descending, *S* sigmoid, *RS* recto, sigmoid, *R* rectum, *S* synchronous, *M* metachronous, *BSO* bilateral salpingo-oophorectomy, *ATH* abdominal total hysterectomy, *LO* left oophorectomy, *RO* right oophorectomy, *na* not applicable, *nd* not documented

The mean age was 49 ± 9 years (range 32--65 years), and the primary site of colorectal cancers included the cecum 2, ascending colon 6, transversus colon 1, descending colon 2, sigmoid colon 13, and rectum 4 patients. The histologic type of colon cancers was well to moderately differentiated adenocarcinoma, except one case which was reported to be poorly differentiated adenocarcinoma.

The onset of pseudo-Meigs' syndrome was 75 % (21/28) synchronous and 25 % (7/28) metachronous, while a case that developed both synchronous and metachronous, similar to the present case, was not reported.

Nearly all cases had ascites except two cases that developed only pleural effusion. Additionally, all cases had pleural effusions, unilaterally in 16 cases (55 %) (14 on the right side, 2 on the left side) and bilaterally in 13 cases (45 %). The serum level of CA125 was elevated at 557 ± 323 U/ml (range 67--1400 U/ml) in nearly all cases.

Concerning metastatic ovarian tumors, the mean tumor size measured 18 ± 5 cm (range −30 cm), and 15 of 29 cases (52 %) had metastatic ovarian carcinoma on both sides, while no laterality was found in unilateral cases. According to these results, bilateral salpingo-oophorectomy (BSO) should be performed in cases diagnosed with pseudo-Meigs' syndrome. The present case, which demonstrated repeated pseudo-Meigs' syndrome, also emphasizes the necessity of BSO.

The primary clinical challenge for pseudo-Meigs' syndrome is the misdiagnosis with carcinomatous peritonitis or pleuritis. The condition of patients with pseudo-Meigs' syndrome is often confused with terminal stage malignant disease, for which surgical treatment is not indicated except for a palliative surgery. In the previously reported cases, pleural effusions and ascites rapidly recovered after the removal of the ovarian tumors. Moreover, the patients achieved long survivals (Table [1](#Tab1){ref-type="table"}), especially the present patient who achieved a 7-year disease-free survival. According to these findings, the pathophysiology of pseudo-Meigs' syndrome must be distinguished from carcinomatous peritonitis and/or pleuritis of malignant disease. If repeated cytology for effusions is negative for malignant cells, we might have a chance to achieve curative operation.

Conclusions {#Sec4}
===========

We herein reported a case with pseudo-Meigs' syndrome due to ovarian metastases from colon cancer. The patient developed both synchronous and metachronous ovarian metastases and achieved 7-year disease-free survival after the operation. The pathophysiology of pseudo-Meigs' syndrome must be distinguished from carcinomatous peritonitis and/or pleuritis of malignant disease.
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